Hong Kong Life Sciences and Technologies Group Limited reported unaudited consolidated earnings results for the second quarter and six months ended September 30, 2018. For the quarter, the company reported revenue of HKD 6,507,000 against HKD 43,666,000 a year ago. Loss before tax was HKD 866,000 against HKD 338,000 a year ago. Loss for the period attributable to owners of the company was HKD 855,000 against profit for the period attributable to owners of the company of HKD 52,000 a year ago. Loss per basic and diluted share was 0.02 cents against profit of 0.01 cents a year ago. For the six months, the company reported revenue of HKD 13,036,000 against HKD 86,960,000 a year ago. Profit before tax was HKD 3,678,000 against loss of HKD 1,542,000 a year ago. Profit for the period attributable to owners of the company was HKD 3,704,000 against loss of HKD 752,000 a year ago. Earnings per basic and diluted share were 0.06 cents against loss of 0.01 cents a year ago. Net cash used in operating activities was HKD 3,508,000 against HKD 39,196,000 a year ago. The significant decrease in revenue as mainly derived from the trading business.